Earningsreport

Q2/2025 6/30/2025 EPS -0.610 ZacksConsensus -0.630 ActVsEst 0.020 - Beat

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx